Proton therapy is a form of radiation therapy, that leverages the unique properties of protons to maximize dose deposition in treatment volumes. The usefulness of proton therapy treatment, in sparing healthy tissue, becomes even more evident with the incorporation of the FLASH ef
...
Proton therapy is a form of radiation therapy, that leverages the unique properties of protons to maximize dose deposition in treatment volumes. The usefulness of proton therapy treatment, in sparing healthy tissue, becomes even more evident with the incorporation of the FLASH effect. FLASH delivers ultra-high dose rates with minimal treatment time while maintaining therapeutic efficiency in eradicating tumours. How- ever, due to practical challenges such as energy layer switching in pencil beam scanning systems the clinical applications are limited. This thesis researched the development of patient-specific ridge filters (RFs) for proton therapy using an optimization algorithm. Ridge filters are energy modulators that help enable dose delivery without energy layer switching, making the FLASH effect feasible as was shown in 2018 [1]. Previous studies used static and dynamic methods [2] and fluence-based optimization [3] to construct patient-specific RFs. This study presents a novel framework for optimizing patient-specific RFs using a combination of TOPAS, a Monte Carlo particle simulation software that accurately models particle transport, and PyGAD, a Python-based genetic algorithm (GA) module. This class of optimizers is effective in cases where no derivatives are avail- able or are very difficult to compute. GAs do this by testing various simulations and evaluating these using a fitness function. The methodology involves simulating dose distribution in a scoring volume, optimizing ridge pin geometry, and evaluating performance using fitness functions. The results demonstrate that the proposed framework effectively generates patient-specific RFs with min- imal deviation from the desired dose distribution in simple cases, with a maximum dose difference of 2.66 % and mean dose of 99.21 % over the region of interest. Comparative analysis with prior approaches shows that the framework achieves similar results. However, applying the framework to cases with obstructions in the scoring volume requires further refinement of the algorithm. The findings provide a basis for using GAs for constructing patient-specific RFs for FLASH proton therapy. Future work should be aimed at refining the GA and Monte Carlo simulation and assessing the viability of producing the generated RFs.